SlideShare a Scribd company logo
1 of 120
Self-Evaluation Process
         2012 Update in Critical Care Medicine
             Module A2-M Version 2012-1

                                          Confidential
            Only for use at the Scott & White Learning Sessions held July 16th 2012.

WARNING: This Self-Evaluation Process (SEP) is copyrighted work under the Federal Copyright Act. It is a federal
criminal offense to copy or reproduce this work in any manner or to make adaptations of this work. It is also a crime
to knowingly assist someone else in the infringement of a copyrighted work. No part of this work may be reproduced
by any means or transmitted in any form or by any means (electronic, mechanical, photocopying, recording, or
otherwise) without the prior written permission of the American Board of Internal Medicine. The making of
adaptations from this work also is strictly forbidden. In addition to criminal penalties, the Copyright Act, 17
U.S.C.§§101, et seq., provides a number of remedies for the infringement of a copyright, including injunctive relief,
the award of statutory and actual damages, the award of attorney fees and costs, and confiscation and destruction of
infringing works and materials. It is the policy of the Board to strictly enforce its rights to this copyrighted work.
31st Annual Internal Medicine Review
                      July 16th 2011




Stephen Sibbitt, MD, FACP         Curtis Mirkes, DO, FACP
   CMO Scott & White                  Program Director
    Memorial Hospital                   IM Residency
Question 1
Left ventricle (LVAD)
Right ventricle (RVAD)
Both ventricles (BIVAD)

              Utilized
   Heart muscle is damaged and
    needs to rest in order to heal
   Bridge in patients awaiting heart
    transplantation or in patients
    who have rejected a
    transplanted heart.

                                        HeartMate ® Implantable
Question 1
      Classification of HF: Comparison Between ACC/AHA HF Stage &
                            NYHA Functional Class
              ACC/AHA HF Stage1                                            NYHA Functional Class2
                                                                        None
A At high risk for heart failure but without
  structural heart disease or symptoms
  of heart failure (eg, patients with
  hypertension or coronary artery disease)
                                                                    I     Asymptomatic
B Structural heart disease but without
  symptoms of heart failure

                                                                    II Symptomatic with moderate exertion
CStructural heart disease with prior or
  current symptoms of heart failure
                                                                    III Symptomatic with minimal exertion


D Refractory heart failure requiring                                IV Symptomatic at rest
  specialized interventions



                                                                                    1HuntSA et al. J Am Coll Cardiol. 2001;38:2101–2113.
    2New   York Heart Association/Little Brown and Company, 1964. Adapted from: Farrell MH et al. JAMA. 2002;287:890–897.
Question 1
Question 1
Question 1
Question 1




  A.    Continuation of current management
  B.    Placement of a left ventricular assist device
  C.    Plasma exchange
  D.    Proceeding to ABO non-matched heart
        transplantation
Question 2
Beta-lactam antibiotics
 Penicillins
   Ampicillin

   Amoxicillin

   Piperacillin

 Cephalosporins   (generations)
   1st gen: cephalothin
   2nd gen (cephamycins): cefoxitin, cefotetan

   3rd gen: ceftazidime, cefotaxime, ceftriaxone

   4th gen: cefepime
Question 2
Beta-lactam antibiotics
 Monobactam:    aztreonam
 Carbapenems:
   Imipenem

   Meropenem

   Ertapenem

 Inhibitors
   Sulbactam (ampicillin/sulbactam: Unasyn)
   Tazobactam (piperacillin/tazobactam: Zosyn)

   Clavulanate (amoxicillin/clavulanate: Augmentin)
Question 2
Question 2




  A.   If renal function worsens, the dose should be
       decreased, rather than increasing the interval
  B.   The volume of distribution is decreased, necessitating
       a lower loading dose
  C.   The patient may benefit from shorter infusion times
  D.   The Cockcroft-Gault equation will accurately estimate
       the patient's glomerular filtration rate
Question 3




 During severe bacterial infections and sepsis, blood levels rise rapidly (up to
                   x100K) – no elevation from viral infections
Is the Standard of Care for much of Europe in the management of infection and
                                      sepsis

                                                  Morgenthaler N. et al., Clin Lab 2002, 48: 263-270
Question 3
Question 3
Question 3




  A.   An elevated procalcitonin level mitigates
       against myocardial infarction
  B.   A procalcitonin-guided strategy will decrease
       the patient's mortality risk
  C.   A low procalcitonin level makes septic shock
       less likely
  D.   A low procalcitonin level excludes bacteremia
Question 4
   Use ideal body weight for underweight patient
   Use adjusted body weight for overweight patient

                   Ideal body weight =
    ((Body height cm)-100) – (10% x (Body height-100))

                Adjusted body weight =
    Actual body weight (ABW) – (25% x (Actual Body
               Weight- Ideal Body Weight))
Question 4
Question 4
Question 4




  A.   Total parenteral nutrition providing 35 kcal/kg (based
       on actual body weight)
  B.   Enteral nutrition providing 35 kcal/kg (based on
       actual body weight)
  C.   Enteral nutrition providing 22 kcal/kg (based on
       adjusted body weight)
  D.   Combined parenteral and enteral nutrition providing a
       total of 35 kcal/kg (based on ideal body weight)
Question 5
Question 5
Extended-spectrum beta-lactamases (ESBL)
 confer resistance to beta-lactam agents and
 ESBL-containing organisms are multi-drug
 resistant.
Question 5
Question 5
Question 5




  A.    Ceftriaxone
  B.    Ciprofloxacin
  C.    Imipenem-cilastatin
  D.    Piperacillin-tazobactam
Question 6
Central Venous Pressure (CVP):
CVP = right atrial pressure (RAP) = right-
 ventricular end-diastolic pressure (RVEDP)
 (Right Ventricular Preload)

Pulmonary Capillary Wedge Pressure (PCWP)
PCWP = left atrial pressure (LAP) = left-
  ventricular end-diastolic pressure (LVEDP)
  (Left Ventricular Preload)
Question 6
Cardiac Output (CO) = HR x SV (L/min)
     Normal CO = 4 to 8 L/min


Cardiac Index (CI) = CO/BSA (L/min/m2)
     Normal CI = 2.5-4.2 L/min/m2
Question 6
                Etiology & Hemodynamic Changes in Shock
Etiology of        Example         CVP         CO          SVR    VO2 sat
   shock

  Preload         Hypovolemic      Low         Low         High     Low
Contractility      Cardiogenic     High        Low         High     Low
 Afterload                                  Distributive
                  Hyperdynamic   Low/High      High        Low      High
                     Septic
                  Hypodynamic    Low/High      Low         High   Low/High
                     Septic
                   Neurogenic      Low         Low         Low      Low
                  Anaphylactic     Low         Low         Low      Low
Question 6
   Intraaortic Balloon Pump (IABP)
   Counterpulsation is synchronized to the EKG
    or arterial waveforms
   Increase coronary perfusion
   Decrease left ventricular stroke work and
    myocardial oxygen requirements
   Indications for its use include
        Failure to wean from cardiopulmonary
         bypass
        Cardiogenic shock after MI
        Heart failure
        Refractory ventricular arrhythmias with
         ongoing ischemia
Question 6
Question 6
Question 6




  A.    Less anticoagulation is needed
  B.    A higher level of underlying cardiac function is
        required
  C.    Mortality from cardiogenic shock is reduced
  D.    Ventricular loading is reduced, and cardiac
        performance is improved
  E.    Percutaneous left ventricular assist devices can
        be used in severe aortic regurgitation
Question 7
Question 7
Question 7




  A.    Arterial blood gas studies
  B.    Depth of chest wall compression
  C.    Quantitative waveform capnography
  D.    Good air entry on auscultation of the lungs
Question 8
Question 8
Question 8
Question 8




  A.    Rebound hypercoagulability and
        subsequent thromboembolism
  B.    Depletion of thrombin due to the
        surgical acute-phase response
  C.    Thrombogenesis due to postoperative
        hypovolemia
  D.    Decreased fibrin turnover
Question 9


   Medication            Onset     Duration       Side Effects
                         (min)      (min)
Ultra short Acting
       Succinylcholine   1 – 1.5    5 - 10           ↑ K, ICP
Intermediate Acting
          Atracurium       2          30      Rash, Histamine Release
         Rocuronium        1        30 – 60          Expensive
       Cisatracurium      3-6         30
Long Acting
       Pancuronium       1.5 – 2      60
Question 9
Question 9
Question 9




  A.    Succinylcholine is contraindicated following
        thermal injury
  B.    Atracurium is indicated, as it has minimal
        cardiovascular effects in hypotensive patients
  C.    Cisatracurium is indicated because of its
        favorable onset of action
  D.    Rocuronium is contraindicated, as it may
        propagate hypotension
Question 10
Question 10
Question 10




  A.    Decreased incidence of infections
  B.    Increased incidence of burnout
  C.    Decreased job satisfaction
  D.    Increased incidence of cross-contamination
Question 11
   Anion Gap
       140 – 100 – 15 = 25

   Calculated Osmolality
     2 X Na + BUN/2.8 + Glucose/18
     2(140) + 18/2.8 + 130/18

     294


   Osmolal Gap = Measured Osm – Cal Osm
       -4 (normal ≤ 10)
Question 11
Degree of Compensation
For metabolic acidosis,
Expected PCO = 1.5(HCO3) + 8
              2                        2
                   = 1.5(15) + 8 2
                   = 22.5 + 8 2
                   = 30.5 2
                   = 28.5, 32.5

                  7.3 / 30 / 94 / RA
Actual PCO is 30  appropriate compensation
          2
Question 11
Question 11

   Classic clinical triad:
     Mental status changes
     Autonomic hyperactivity
     Neuromuscular abnormalities


   Wide ranging symptoms
Question 11
Question 11
Lactic acid can exist in two forms: L-lactate and
  D-Lactate. In mammals, only the levorotary
  form is a product of metabolism.
D-Lactate can accumulate in humans as a
 byproduct of metabolism by bacteria, which
 accumulate and overgrow in the GI tract with
 jejunal bypass or short bowel syndrome.
The lab measures only L-lactate.
Question 11
                  L-Lactic Acidosis
   Tissue underperfusion      Medical conditions (w/o
                                tissue hypoxia)
     Shock, shock, shock          Hepatic failure
     Hypoxia                      Thiamine deficiency (co-
                                    factor for pyruvate
     Asthma                        dehyrogenase)
                                   Malignancy
     CO poisoning                 Bowel ischemia
                                   Seizures
     Severe anemia                Heat stroke
                                   Tumor lysis
                                   Drugs/Toxins
                                      Metformin (particulary
                                       associated with hypovolemia
                                       and dye)
Question 11
Question 11




  A.    Serotonin syndrome
  B.    Salicylate poisoning
  C.    D-Lactic acidosis
  D.    Vitamin B1 deficiency
  E.    Vitamin B6 deficiency
Question 12
Question 12




  A.    The use of real-time ultrasonography for central line placement has been
        found to decrease the complication rate in all sites of insertion
  B.    Ultrasonography and chest radiography have the same accuracy for
        detection of pleural effusion and parenchymal consolidation in critically
        ill patients
  C.    The Focused Assessment with Sonography for Trauma (FAST) technique
        of point-of-care ultrasonography has been shown to decrease the need
        for computed tomography and to reduce the time to intervention
  D.    The finding of B lines on pleural ultrasonography predicts the presence
        of pneumothorax
Question 13
   Acute Lung Injury
       Bilateral pulmonary infiltrates on chest x-ray
       Pulmonary Capillary Wedge Pressure < 18 mmHg (2.4 kPa)
       PaO2/FiO2* <300 mmHg (40 kPa) = ALI
       PaO2/FiO2 <200 mmHg (26.7 kPa)= ARDS
Question 13
     Direct Insult                   Indirect Insult
Common                           Common
         Aspiration Pneumonia                              Sepsis
                    Pneumonia                      Severe Trauma
                                                           Shock
Less Common                      Less Common
             Inhalation Injury                  Acute Pancreatitis
         Pulmonary contusions         Transfusion Related TRALI
                   Fat Emboli                               DIC
              Near Drowning                          Head Injury
            Reperfusion Injury                             Burns
                                                 Drug Overdose
Question 13
Question 13
Question 13
Potential beneficial prevention strategies
   Mechanical ventilation, tidal volume limited to 6 to 8 mL/kg; maintenance of
    airway pressure at less than 30 cm H2O; use of moderate PEEP level;
   Blood products: limitation of the use of packed red blood cells to evidence-
    based guidelines; limitation of the use of fresh frozen plasma and platelets to
    the setting of actual bleeding;
   Intravenous fluids, maintenance of neutral to negative fluid balance except in
    the setting of shock or during resuscitation;
   Resuscitation timeline: adequate repletion of circulating volume as quickly as
    possible after development of shock; and
   Drug toxicity: avoidance of drugs that have direct pulmonary toxicity, such as
    amiodarone, when possible; another anti-arrhythmic medication should be
    used.
Question 13




  A.    Administration of inhaled corticosteroids to patients who have
        a PO2/FIO2 ratio less than 350 or use of positive end-
        expiratory pressure (PEEP) greater than 8 cm H2O, or both
  B.    Limiting transfusion of fresh frozen plasma and platelets to
        those patients who are actually bleeding
  C.    De-escalation of antibiotics if sputum cultures show no
        growth at 48 hours
  D.    Early bronchoscopy with bronchoalveolar lavage in patients at
        high risk for ventilator-associated pneumonia
Question 14
Question 14
Question 14
Question 14




  A.    The mortality in critically ill medical and surgical patients does
        not differ between hyperglycemic and normoglycemic patients
  B.    Mortality rates are proportional to blood glucose levels in
        critically ill patients who have hyperglycemia
  C.    In patients who have had myocardial infarction, glucose levels
        below the usual target of 140 to 180 mg/dL for critically ill
        patients are recommended for optimal outcome
  D.    After adjustment for severity of illness, hypoglycemia was not
        found to be an independent risk factor for death
Question 15
Question 15
Question 15




  A.    Increased time for return of spontaneous
        circulation
  B.    No difference in survival at 30 days
  C.    Reduced survival if the airway is occluded
  D.    Reduced survival to hospital admission
Question 16
Question 16
Question 16




  A.    Associated with long-term cognitive
        impairment
  B.    Not associated with increased mortality
  C.    Associated with increased length of stay in the
        ICU, but not length of stay in hospital
  D.    Occurs independent of the age of the patient
Question 17
Question 17
Question 17




  A.    A-B-C, referring to opening the airway (A), giving 2
        breaths (B), and 30 chest compressions (C)
  B.    C-A-B, referring to 30 chest compressions (C),
        opening the airway (A), and giving 2 breaths (B)
  C.    C-B-D, referring to 30 chest compressions (C), 2
        breaths (B), and defibrillation (D)
  D.    D-A-B, referring to defibrillation (D), opening the
        airway (A), and 2 breaths (B)
Question 18




IAP should be expressed in mmHg and measured at
 end-expiration in the complete supine position after
   ensuring that abdominal muscle contractions are
 absent and with the transducer zeroed at the level of
                  the midaxillary line.
Question 18

   IAH is graded as follows:
     Grade I      IAP 12 - 15 mmHg
     Grade II     IAP 16 - 20 mmHg
     Grade III    IAP 21 - 25 mmHg
     Grade IV     IAP > 25mmHg.


    The IAH grades have been revised downward as the
      detrimental impact of elevated IAP on end-organ
                function has been recognized
Question 18
 Abdominal  Compartment Syndrome (ACS) is defined as a
 sustained IAP > 20mmHg (with or without an APP <
 60mmHg) that is associated with new organ dysfunction/
 failure.”
 ACS = IAH + organ dysfunction
 The most common organ dysfunction / failure(s) are:
    Metabolic acidosis despite resuscitation
    Oliguria despite volume repletion

    Elevated peak airway pressures

    Hypoxemia refractory to oxygen and PEEP
Question 18




  A.    mm Hg, zeroed to the bladder with the patient
        semirecumbent (head of bed elevated to a 45-degree
        angle)
  B.    cm H2O, zeroed to ear level with the patient in the
        supine position
  C.    mm Hg, zeroed to the mid-axillary line with the patient
        in the supine position
  D.    cm H2O, zeroed to the mid-axillary line with the
        patient in any position
Question 19
Question 19
Question 19




  A.    Both teams should be called when the patient has
        hypotension, tachycardia, respiratory distress, or
        altered consciousness
  B.    Both teams should contain an anesthesiology
        practitioner
  C.    Rapid-response teams typically have a call rate of 5 to
        10 in 1000 admissions, and code teams have a call
        rate of 20 to 40 in 1000 admissions
  D.    Delays in the activation of rapid-response teams and
        code teams have been associated with increased
        mortality
Question 20
Question 20
Question 20




  A.    Emergent magnetic resonance imaging of the
        thoracic spine
  B.    Intravenous corticosteroids
  C.    Norepinephrine
  D.    Emergent placement of an epidural drain
Question 21
Question 21




  A.    Dopamine
  B.    Dobutamine
  C.    Norepinephrine
  D.    Vasopressin
Question 22

   IAH is graded as follows:
     Grade I      IAP 12 - 15 mmHg
     Grade II     IAP 16 - 20 mmHg
     Grade III    IAP 21 - 25 mmHg
     Grade IV     IAP > 25mmHg.


    The IAH grades have been revised downward as the
      detrimental impact of elevated IAP on end-organ
                function has been recognized
Question 22




  A.    Grade I, less than 5 mm Hg; Grade IV, greater
        than 40 mm Hg
  B.    Grade I, greater than 25 mm Hg; Grade IV,
        less than 50 mm Hg
  C.    Grade I, 5-10 mm Hg; Grade IV, greater than
        50 mm Hg
  D.    Grade I, 12-15 mm Hg; Grade IV, greater than
        25 mm Hg
Question 23
Question 23




  A.    In all infections regardless of the risk of death
  B.    In patients with witnessed aspiration
  C.    Only in immunosuppressed patients
  D.    Only in serious infections when the risk of
        death with monotherapy is greater than 25%
Question 24
Question 24




Tidal Volume (mL) Plateau Pressure/PEEP (cm H2O)   FIO2   PO2 (mmHg)
A.   700                  20/10                           1.0    100
B.   320                  35/18                           1.0    60
C.   540                  30/14                           0.7    105
D.   500                  25/5                            0.5    120
Question 25
   Routes of                 Cocaine Pharmacokinetics:
    administration                   Absorption
     Insufflated (snorted)
     IV (mainlined)
     Inhaled (freebased)
     Oral
Question 25
   Cocaethylene
   Alcohol inhibits metabolism of cocaine
   Alcohol + cocaine chemically react to form cocaethylene

• Cocaethylene Effects
      – Similar effects to cocaine
      – Greater cardiac toxicity than cocaine
      – 3-5x the half-life of cocaine
      – Associated with seizures, liver damage,
        compromised immune system
Question 25
Question 25




  A.    Acute respiratory distress syndrome
  B.    Propylene glycol intoxication
  C.    Mesenteric ischemia
  D.    Cocaethylene formation
Question 26
Question 26
Question 26
Question 26




  A.    His prognosis for return of renal function to baseline is
        better than those of patients who have impaired left
        ventricular function
  B.    In patients who have type 1 cardiorenal syndrome, the
        use of beta-adrenergic blockers worsens mortality
  C.    This patient's acute on chronic renal dysfunction
        probably caused his acute heart failure (type 3 acute
        renocardiac syndrome)
  D.    Addition of an angiotensin-converting enzyme inhibitor
        drug to this patient's chronic regimen will improve his 12-
        month mortality
Question 27
Question 27
Question 27




  A.    Continue current management
  B.    Discontinue albuterol nebulization
  C.    Change intravenous fluid to 5% dextrose in
        water with 2 ampules of bicarbonate
        (100 mEq/L)
  D.    Administer tromethamine (TRIS) buffer
Pressure ventilation vs. volume ventilation
    Pressure-cycled modes deliver a fixed pressure at variable volume
    Volume-cycled modes deliver a fixed volume at variable pressure

• Pressure-cycled modes
  • Pressure Support Ventilation (PSV)
  • Pressure Control Ventilation (PCV)
  • CPAP
  • BiPAP
• Volume-cycled modes
  • Control                                 Volume-cycled modes have the inherent
  • Assist                                           risk of volutrauma.

  • Assist/Control
  • Intermittent Mandatory Ventilation
    (IMV)
  • Synchronous Intermittent
    Mandatory Ventilation (SIMV)
Question 28
Question 28
Question 28




  A.    The modality allows the patient to define their
        inspiratory flow rate and tidal volume
  B.    The incidence of barotrauma is less
  C.    The need for tracheostomy to facilitate
        weaning is less
  D.    Closed loop technology automatically adjusts
        the FIO2
Question 29

Posterior reversible encephalopathy syndrome
                     (PRES)
Question 29
      Conditions at Risk for
             PRES




                   AJR 2008;29:1036-42
Question 29
Question 29




  A.    Contrast-enhanced magnetic resonance
        imaging of the brain
  B.    Lumbar puncture and cerebrospinal fluid
        examination
  C.    Intravenous contrast-enhanced computed
        tomography of the head
  D.    Cerebral angiography
Question 30
Question 30




  A.    Discontinuation of lorazepam
  B.    Initiation of zolpidem
  C.    Discontinuation of methylprednisolone
  D.    Discontinuation of inhaled beta-adrenergic
        agonists
Questions?

More Related Content

What's hot

The j wave dr. sharfuddin chowdhury
The j wave  dr. sharfuddin chowdhuryThe j wave  dr. sharfuddin chowdhury
The j wave dr. sharfuddin chowdhury
Shakila Rifat
 
Ami Selayang Hospital
Ami Selayang HospitalAmi Selayang Hospital
Ami Selayang Hospital
Rashidi Ahmad
 
高亮:Traumatic Brain Injury Associated Coagulopathy
高亮:Traumatic Brain Injury Associated Coagulopathy高亮:Traumatic Brain Injury Associated Coagulopathy
高亮:Traumatic Brain Injury Associated Coagulopathy
neuroccm
 
Hypocalcemia induced camel-hump t-wave, tee-pee sign, and bradycardia in a ca...
Hypocalcemia induced camel-hump t-wave, tee-pee sign, and bradycardia in a ca...Hypocalcemia induced camel-hump t-wave, tee-pee sign, and bradycardia in a ca...
Hypocalcemia induced camel-hump t-wave, tee-pee sign, and bradycardia in a ca...
YasserMohammedHassan1
 
Brugada Syndrome, Sbcc 2012
Brugada Syndrome, Sbcc 2012Brugada Syndrome, Sbcc 2012
Brugada Syndrome, Sbcc 2012
salah_atta
 

What's hot (20)

A&e answers
A&e answersA&e answers
A&e answers
 
Role of plasma N-terminal proB-type natriuretic peptide (NT-proBNP) level in ...
Role of plasma N-terminal proB-type natriuretic peptide (NT-proBNP) level in ...Role of plasma N-terminal proB-type natriuretic peptide (NT-proBNP) level in ...
Role of plasma N-terminal proB-type natriuretic peptide (NT-proBNP) level in ...
 
Critical care revision notes
Critical care revision notesCritical care revision notes
Critical care revision notes
 
The j wave dr. sharfuddin chowdhury
The j wave  dr. sharfuddin chowdhuryThe j wave  dr. sharfuddin chowdhury
The j wave dr. sharfuddin chowdhury
 
myocardial Reperfusion injury
myocardial Reperfusion injurymyocardial Reperfusion injury
myocardial Reperfusion injury
 
Ami Selayang Hospital
Ami Selayang HospitalAmi Selayang Hospital
Ami Selayang Hospital
 
Cardiac Channelopathies
Cardiac ChannelopathiesCardiac Channelopathies
Cardiac Channelopathies
 
Electrocardiographic passing phenomenon (flying phenomenon or yasser’s phenom...
Electrocardiographic passing phenomenon (flying phenomenon or yasser’s phenom...Electrocardiographic passing phenomenon (flying phenomenon or yasser’s phenom...
Electrocardiographic passing phenomenon (flying phenomenon or yasser’s phenom...
 
高亮:Traumatic Brain Injury Associated Coagulopathy
高亮:Traumatic Brain Injury Associated Coagulopathy高亮:Traumatic Brain Injury Associated Coagulopathy
高亮:Traumatic Brain Injury Associated Coagulopathy
 
Repolarization syndromes
Repolarization syndromesRepolarization syndromes
Repolarization syndromes
 
Hypocalcemia induced camel-hump t-wave, tee-pee sign, and bradycardia in a ca...
Hypocalcemia induced camel-hump t-wave, tee-pee sign, and bradycardia in a ca...Hypocalcemia induced camel-hump t-wave, tee-pee sign, and bradycardia in a ca...
Hypocalcemia induced camel-hump t-wave, tee-pee sign, and bradycardia in a ca...
 
Cardiac chanellopathies
Cardiac chanellopathiesCardiac chanellopathies
Cardiac chanellopathies
 
Brugada Syndrome, Sbcc 2012
Brugada Syndrome, Sbcc 2012Brugada Syndrome, Sbcc 2012
Brugada Syndrome, Sbcc 2012
 
Approach to Channelopathies ppt
Approach to  Channelopathies pptApproach to  Channelopathies ppt
Approach to Channelopathies ppt
 
Wavy triple an ECG sign (Yasser’s sign) in hypocalcaemia -Cardiology and Eme...
Wavy triple an ECG sign (Yasser’s sign) in hypocalcaemia -Cardiology  and Eme...Wavy triple an ECG sign (Yasser’s sign) in hypocalcaemia -Cardiology  and Eme...
Wavy triple an ECG sign (Yasser’s sign) in hypocalcaemia -Cardiology and Eme...
 
Cardiovascular ischemia - reperfusion injury
Cardiovascular   ischemia - reperfusion injuryCardiovascular   ischemia - reperfusion injury
Cardiovascular ischemia - reperfusion injury
 
Natriuretic peptide in chf and acs,VIRBHAN
Natriuretic peptide in chf and acs,VIRBHANNatriuretic peptide in chf and acs,VIRBHAN
Natriuretic peptide in chf and acs,VIRBHAN
 
Cardiology cases ppt 4slideshare
Cardiology cases ppt 4slideshareCardiology cases ppt 4slideshare
Cardiology cases ppt 4slideshare
 
Hypertonic Saline Versus Mannitol for Increased Intracranial Pressure Management
Hypertonic Saline Versus Mannitol for Increased Intracranial Pressure ManagementHypertonic Saline Versus Mannitol for Increased Intracranial Pressure Management
Hypertonic Saline Versus Mannitol for Increased Intracranial Pressure Management
 
Guillain - Barre syndrome after acute myocardial infarction: A rare presentat...
Guillain - Barre syndrome after acute myocardial infarction: A rare presentat...Guillain - Barre syndrome after acute myocardial infarction: A rare presentat...
Guillain - Barre syndrome after acute myocardial infarction: A rare presentat...
 

Similar to 2012 critical care updates participation slides

Heart failure – an update [autosaved]
Heart failure – an update [autosaved]Heart failure – an update [autosaved]
Heart failure – an update [autosaved]
SMSRAZA
 
Case Presentations 1
Case Presentations 1Case Presentations 1
Case Presentations 1
Gamal Agmy
 
Severe Sepsis & Septic Shock
Severe Sepsis & Septic ShockSevere Sepsis & Septic Shock
Severe Sepsis & Septic Shock
Andrew Ferguson
 

Similar to 2012 critical care updates participation slides (20)

Heart failure – an update [autosaved]
Heart failure – an update [autosaved]Heart failure – an update [autosaved]
Heart failure – an update [autosaved]
 
Heart failure – an update
Heart failure – an updateHeart failure – an update
Heart failure – an update
 
Pathogroup2
Pathogroup2Pathogroup2
Pathogroup2
 
Cardiac arrest seminar
Cardiac arrest seminarCardiac arrest seminar
Cardiac arrest seminar
 
3,4- Anti-arrhythmic drugs.pptx
3,4- Anti-arrhythmic drugs.pptx3,4- Anti-arrhythmic drugs.pptx
3,4- Anti-arrhythmic drugs.pptx
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
 
Board Review
Board ReviewBoard Review
Board Review
 
Oncologcial Emergencies by Prof Ahmed Badheeb 2014 part 1
Oncologcial  Emergencies by Prof Ahmed Badheeb 2014 part 1Oncologcial  Emergencies by Prof Ahmed Badheeb 2014 part 1
Oncologcial Emergencies by Prof Ahmed Badheeb 2014 part 1
 
S
SS
S
 
Shock its pathopysiology and management
Shock its pathopysiology and managementShock its pathopysiology and management
Shock its pathopysiology and management
 
Bradyarrhythmias and Devices
Bradyarrhythmias and Devices Bradyarrhythmias and Devices
Bradyarrhythmias and Devices
 
Case Presentations 1
Case Presentations 1Case Presentations 1
Case Presentations 1
 
PICU OSCE.pdf
PICU OSCE.pdfPICU OSCE.pdf
PICU OSCE.pdf
 
Severe Sepsis & Septic Shock
Severe Sepsis & Septic ShockSevere Sepsis & Septic Shock
Severe Sepsis & Septic Shock
 
OSCE - Pune mock OSCE 2012
OSCE - Pune mock OSCE 2012OSCE - Pune mock OSCE 2012
OSCE - Pune mock OSCE 2012
 
Approach to heart failure cases
Approach to heart failure casesApproach to heart failure cases
Approach to heart failure cases
 
Sudden Cardiac Death
Sudden Cardiac DeathSudden Cardiac Death
Sudden Cardiac Death
 
Acute Decompensated Heart Failure
Acute Decompensated Heart FailureAcute Decompensated Heart Failure
Acute Decompensated Heart Failure
 
Acute Decompensated Heart Failure CSI13
Acute Decompensated Heart Failure CSI13Acute Decompensated Heart Failure CSI13
Acute Decompensated Heart Failure CSI13
 
Sudden Cardiac Death
Sudden Cardiac Death Sudden Cardiac Death
Sudden Cardiac Death
 

Recently uploaded

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 

Recently uploaded (20)

latest AZ-104 Exam Questions and Answers
latest AZ-104 Exam Questions and Answerslatest AZ-104 Exam Questions and Answers
latest AZ-104 Exam Questions and Answers
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 

2012 critical care updates participation slides

  • 1. Self-Evaluation Process 2012 Update in Critical Care Medicine Module A2-M Version 2012-1 Confidential Only for use at the Scott & White Learning Sessions held July 16th 2012. WARNING: This Self-Evaluation Process (SEP) is copyrighted work under the Federal Copyright Act. It is a federal criminal offense to copy or reproduce this work in any manner or to make adaptations of this work. It is also a crime to knowingly assist someone else in the infringement of a copyrighted work. No part of this work may be reproduced by any means or transmitted in any form or by any means (electronic, mechanical, photocopying, recording, or otherwise) without the prior written permission of the American Board of Internal Medicine. The making of adaptations from this work also is strictly forbidden. In addition to criminal penalties, the Copyright Act, 17 U.S.C.§§101, et seq., provides a number of remedies for the infringement of a copyright, including injunctive relief, the award of statutory and actual damages, the award of attorney fees and costs, and confiscation and destruction of infringing works and materials. It is the policy of the Board to strictly enforce its rights to this copyrighted work.
  • 2. 31st Annual Internal Medicine Review July 16th 2011 Stephen Sibbitt, MD, FACP Curtis Mirkes, DO, FACP CMO Scott & White Program Director Memorial Hospital IM Residency
  • 3. Question 1 Left ventricle (LVAD) Right ventricle (RVAD) Both ventricles (BIVAD) Utilized  Heart muscle is damaged and needs to rest in order to heal  Bridge in patients awaiting heart transplantation or in patients who have rejected a transplanted heart. HeartMate ® Implantable
  • 4. Question 1 Classification of HF: Comparison Between ACC/AHA HF Stage & NYHA Functional Class ACC/AHA HF Stage1 NYHA Functional Class2 None A At high risk for heart failure but without structural heart disease or symptoms of heart failure (eg, patients with hypertension or coronary artery disease) I Asymptomatic B Structural heart disease but without symptoms of heart failure II Symptomatic with moderate exertion CStructural heart disease with prior or current symptoms of heart failure III Symptomatic with minimal exertion D Refractory heart failure requiring IV Symptomatic at rest specialized interventions 1HuntSA et al. J Am Coll Cardiol. 2001;38:2101–2113. 2New York Heart Association/Little Brown and Company, 1964. Adapted from: Farrell MH et al. JAMA. 2002;287:890–897.
  • 8. Question 1 A. Continuation of current management B. Placement of a left ventricular assist device C. Plasma exchange D. Proceeding to ABO non-matched heart transplantation
  • 9. Question 2 Beta-lactam antibiotics  Penicillins  Ampicillin  Amoxicillin  Piperacillin  Cephalosporins (generations)  1st gen: cephalothin  2nd gen (cephamycins): cefoxitin, cefotetan  3rd gen: ceftazidime, cefotaxime, ceftriaxone  4th gen: cefepime
  • 10. Question 2 Beta-lactam antibiotics  Monobactam: aztreonam  Carbapenems:  Imipenem  Meropenem  Ertapenem  Inhibitors  Sulbactam (ampicillin/sulbactam: Unasyn)  Tazobactam (piperacillin/tazobactam: Zosyn)  Clavulanate (amoxicillin/clavulanate: Augmentin)
  • 12.
  • 13. Question 2 A. If renal function worsens, the dose should be decreased, rather than increasing the interval B. The volume of distribution is decreased, necessitating a lower loading dose C. The patient may benefit from shorter infusion times D. The Cockcroft-Gault equation will accurately estimate the patient's glomerular filtration rate
  • 14. Question 3 During severe bacterial infections and sepsis, blood levels rise rapidly (up to x100K) – no elevation from viral infections Is the Standard of Care for much of Europe in the management of infection and sepsis Morgenthaler N. et al., Clin Lab 2002, 48: 263-270
  • 17. Question 3 A. An elevated procalcitonin level mitigates against myocardial infarction B. A procalcitonin-guided strategy will decrease the patient's mortality risk C. A low procalcitonin level makes septic shock less likely D. A low procalcitonin level excludes bacteremia
  • 18. Question 4  Use ideal body weight for underweight patient  Use adjusted body weight for overweight patient Ideal body weight = ((Body height cm)-100) – (10% x (Body height-100)) Adjusted body weight = Actual body weight (ABW) – (25% x (Actual Body Weight- Ideal Body Weight))
  • 21. Question 4 A. Total parenteral nutrition providing 35 kcal/kg (based on actual body weight) B. Enteral nutrition providing 35 kcal/kg (based on actual body weight) C. Enteral nutrition providing 22 kcal/kg (based on adjusted body weight) D. Combined parenteral and enteral nutrition providing a total of 35 kcal/kg (based on ideal body weight)
  • 23. Question 5 Extended-spectrum beta-lactamases (ESBL) confer resistance to beta-lactam agents and ESBL-containing organisms are multi-drug resistant.
  • 26. Question 5 A. Ceftriaxone B. Ciprofloxacin C. Imipenem-cilastatin D. Piperacillin-tazobactam
  • 27. Question 6 Central Venous Pressure (CVP): CVP = right atrial pressure (RAP) = right- ventricular end-diastolic pressure (RVEDP) (Right Ventricular Preload) Pulmonary Capillary Wedge Pressure (PCWP) PCWP = left atrial pressure (LAP) = left- ventricular end-diastolic pressure (LVEDP) (Left Ventricular Preload)
  • 28. Question 6 Cardiac Output (CO) = HR x SV (L/min) Normal CO = 4 to 8 L/min Cardiac Index (CI) = CO/BSA (L/min/m2) Normal CI = 2.5-4.2 L/min/m2
  • 29. Question 6 Etiology & Hemodynamic Changes in Shock Etiology of Example CVP CO SVR VO2 sat shock Preload Hypovolemic Low Low High Low Contractility Cardiogenic High Low High Low Afterload Distributive Hyperdynamic Low/High High Low High Septic Hypodynamic Low/High Low High Low/High Septic Neurogenic Low Low Low Low Anaphylactic Low Low Low Low
  • 30. Question 6  Intraaortic Balloon Pump (IABP)  Counterpulsation is synchronized to the EKG or arterial waveforms  Increase coronary perfusion  Decrease left ventricular stroke work and myocardial oxygen requirements  Indications for its use include  Failure to wean from cardiopulmonary bypass  Cardiogenic shock after MI  Heart failure  Refractory ventricular arrhythmias with ongoing ischemia
  • 33. Question 6 A. Less anticoagulation is needed B. A higher level of underlying cardiac function is required C. Mortality from cardiogenic shock is reduced D. Ventricular loading is reduced, and cardiac performance is improved E. Percutaneous left ventricular assist devices can be used in severe aortic regurgitation
  • 34.
  • 37. Question 7 A. Arterial blood gas studies B. Depth of chest wall compression C. Quantitative waveform capnography D. Good air entry on auscultation of the lungs
  • 38.
  • 42. Question 8 A. Rebound hypercoagulability and subsequent thromboembolism B. Depletion of thrombin due to the surgical acute-phase response C. Thrombogenesis due to postoperative hypovolemia D. Decreased fibrin turnover
  • 43. Question 9 Medication Onset Duration Side Effects (min) (min) Ultra short Acting Succinylcholine 1 – 1.5 5 - 10 ↑ K, ICP Intermediate Acting Atracurium 2 30 Rash, Histamine Release Rocuronium 1 30 – 60 Expensive Cisatracurium 3-6 30 Long Acting Pancuronium 1.5 – 2 60
  • 46. Question 9 A. Succinylcholine is contraindicated following thermal injury B. Atracurium is indicated, as it has minimal cardiovascular effects in hypotensive patients C. Cisatracurium is indicated because of its favorable onset of action D. Rocuronium is contraindicated, as it may propagate hypotension
  • 49. Question 10 A. Decreased incidence of infections B. Increased incidence of burnout C. Decreased job satisfaction D. Increased incidence of cross-contamination
  • 50. Question 11  Anion Gap  140 – 100 – 15 = 25  Calculated Osmolality  2 X Na + BUN/2.8 + Glucose/18  2(140) + 18/2.8 + 130/18  294  Osmolal Gap = Measured Osm – Cal Osm  -4 (normal ≤ 10)
  • 51. Question 11 Degree of Compensation For metabolic acidosis, Expected PCO = 1.5(HCO3) + 8 2 2 = 1.5(15) + 8 2 = 22.5 + 8 2 = 30.5 2 = 28.5, 32.5 7.3 / 30 / 94 / RA Actual PCO is 30  appropriate compensation 2
  • 53. Question 11  Classic clinical triad:  Mental status changes  Autonomic hyperactivity  Neuromuscular abnormalities  Wide ranging symptoms
  • 55. Question 11 Lactic acid can exist in two forms: L-lactate and D-Lactate. In mammals, only the levorotary form is a product of metabolism. D-Lactate can accumulate in humans as a byproduct of metabolism by bacteria, which accumulate and overgrow in the GI tract with jejunal bypass or short bowel syndrome. The lab measures only L-lactate.
  • 56. Question 11 L-Lactic Acidosis  Tissue underperfusion  Medical conditions (w/o tissue hypoxia)  Shock, shock, shock  Hepatic failure  Hypoxia  Thiamine deficiency (co- factor for pyruvate  Asthma dehyrogenase)  Malignancy  CO poisoning  Bowel ischemia  Seizures  Severe anemia  Heat stroke  Tumor lysis  Drugs/Toxins  Metformin (particulary associated with hypovolemia and dye)
  • 58. Question 11 A. Serotonin syndrome B. Salicylate poisoning C. D-Lactic acidosis D. Vitamin B1 deficiency E. Vitamin B6 deficiency
  • 60. Question 12 A. The use of real-time ultrasonography for central line placement has been found to decrease the complication rate in all sites of insertion B. Ultrasonography and chest radiography have the same accuracy for detection of pleural effusion and parenchymal consolidation in critically ill patients C. The Focused Assessment with Sonography for Trauma (FAST) technique of point-of-care ultrasonography has been shown to decrease the need for computed tomography and to reduce the time to intervention D. The finding of B lines on pleural ultrasonography predicts the presence of pneumothorax
  • 61. Question 13  Acute Lung Injury  Bilateral pulmonary infiltrates on chest x-ray  Pulmonary Capillary Wedge Pressure < 18 mmHg (2.4 kPa)  PaO2/FiO2* <300 mmHg (40 kPa) = ALI  PaO2/FiO2 <200 mmHg (26.7 kPa)= ARDS
  • 62. Question 13 Direct Insult Indirect Insult Common Common Aspiration Pneumonia Sepsis Pneumonia Severe Trauma Shock Less Common Less Common Inhalation Injury Acute Pancreatitis Pulmonary contusions Transfusion Related TRALI Fat Emboli DIC Near Drowning Head Injury Reperfusion Injury Burns Drug Overdose
  • 65. Question 13 Potential beneficial prevention strategies  Mechanical ventilation, tidal volume limited to 6 to 8 mL/kg; maintenance of airway pressure at less than 30 cm H2O; use of moderate PEEP level;  Blood products: limitation of the use of packed red blood cells to evidence- based guidelines; limitation of the use of fresh frozen plasma and platelets to the setting of actual bleeding;  Intravenous fluids, maintenance of neutral to negative fluid balance except in the setting of shock or during resuscitation;  Resuscitation timeline: adequate repletion of circulating volume as quickly as possible after development of shock; and  Drug toxicity: avoidance of drugs that have direct pulmonary toxicity, such as amiodarone, when possible; another anti-arrhythmic medication should be used.
  • 66. Question 13 A. Administration of inhaled corticosteroids to patients who have a PO2/FIO2 ratio less than 350 or use of positive end- expiratory pressure (PEEP) greater than 8 cm H2O, or both B. Limiting transfusion of fresh frozen plasma and platelets to those patients who are actually bleeding C. De-escalation of antibiotics if sputum cultures show no growth at 48 hours D. Early bronchoscopy with bronchoalveolar lavage in patients at high risk for ventilator-associated pneumonia
  • 70. Question 14 A. The mortality in critically ill medical and surgical patients does not differ between hyperglycemic and normoglycemic patients B. Mortality rates are proportional to blood glucose levels in critically ill patients who have hyperglycemia C. In patients who have had myocardial infarction, glucose levels below the usual target of 140 to 180 mg/dL for critically ill patients are recommended for optimal outcome D. After adjustment for severity of illness, hypoglycemia was not found to be an independent risk factor for death
  • 73. Question 15 A. Increased time for return of spontaneous circulation B. No difference in survival at 30 days C. Reduced survival if the airway is occluded D. Reduced survival to hospital admission
  • 76. Question 16 A. Associated with long-term cognitive impairment B. Not associated with increased mortality C. Associated with increased length of stay in the ICU, but not length of stay in hospital D. Occurs independent of the age of the patient
  • 79. Question 17 A. A-B-C, referring to opening the airway (A), giving 2 breaths (B), and 30 chest compressions (C) B. C-A-B, referring to 30 chest compressions (C), opening the airway (A), and giving 2 breaths (B) C. C-B-D, referring to 30 chest compressions (C), 2 breaths (B), and defibrillation (D) D. D-A-B, referring to defibrillation (D), opening the airway (A), and 2 breaths (B)
  • 80. Question 18 IAP should be expressed in mmHg and measured at end-expiration in the complete supine position after ensuring that abdominal muscle contractions are absent and with the transducer zeroed at the level of the midaxillary line.
  • 81. Question 18  IAH is graded as follows:  Grade I IAP 12 - 15 mmHg  Grade II IAP 16 - 20 mmHg  Grade III IAP 21 - 25 mmHg  Grade IV IAP > 25mmHg. The IAH grades have been revised downward as the detrimental impact of elevated IAP on end-organ function has been recognized
  • 82. Question 18  Abdominal Compartment Syndrome (ACS) is defined as a sustained IAP > 20mmHg (with or without an APP < 60mmHg) that is associated with new organ dysfunction/ failure.”  ACS = IAH + organ dysfunction  The most common organ dysfunction / failure(s) are:  Metabolic acidosis despite resuscitation  Oliguria despite volume repletion  Elevated peak airway pressures  Hypoxemia refractory to oxygen and PEEP
  • 83. Question 18 A. mm Hg, zeroed to the bladder with the patient semirecumbent (head of bed elevated to a 45-degree angle) B. cm H2O, zeroed to ear level with the patient in the supine position C. mm Hg, zeroed to the mid-axillary line with the patient in the supine position D. cm H2O, zeroed to the mid-axillary line with the patient in any position
  • 86. Question 19 A. Both teams should be called when the patient has hypotension, tachycardia, respiratory distress, or altered consciousness B. Both teams should contain an anesthesiology practitioner C. Rapid-response teams typically have a call rate of 5 to 10 in 1000 admissions, and code teams have a call rate of 20 to 40 in 1000 admissions D. Delays in the activation of rapid-response teams and code teams have been associated with increased mortality
  • 89. Question 20 A. Emergent magnetic resonance imaging of the thoracic spine B. Intravenous corticosteroids C. Norepinephrine D. Emergent placement of an epidural drain
  • 91. Question 21 A. Dopamine B. Dobutamine C. Norepinephrine D. Vasopressin
  • 92. Question 22  IAH is graded as follows:  Grade I IAP 12 - 15 mmHg  Grade II IAP 16 - 20 mmHg  Grade III IAP 21 - 25 mmHg  Grade IV IAP > 25mmHg. The IAH grades have been revised downward as the detrimental impact of elevated IAP on end-organ function has been recognized
  • 93. Question 22 A. Grade I, less than 5 mm Hg; Grade IV, greater than 40 mm Hg B. Grade I, greater than 25 mm Hg; Grade IV, less than 50 mm Hg C. Grade I, 5-10 mm Hg; Grade IV, greater than 50 mm Hg D. Grade I, 12-15 mm Hg; Grade IV, greater than 25 mm Hg
  • 95. Question 23 A. In all infections regardless of the risk of death B. In patients with witnessed aspiration C. Only in immunosuppressed patients D. Only in serious infections when the risk of death with monotherapy is greater than 25%
  • 97. Question 24 Tidal Volume (mL) Plateau Pressure/PEEP (cm H2O) FIO2 PO2 (mmHg) A. 700 20/10 1.0 100 B. 320 35/18 1.0 60 C. 540 30/14 0.7 105 D. 500 25/5 0.5 120
  • 98. Question 25  Routes of Cocaine Pharmacokinetics: administration Absorption  Insufflated (snorted)  IV (mainlined)  Inhaled (freebased)  Oral
  • 99. Question 25  Cocaethylene  Alcohol inhibits metabolism of cocaine  Alcohol + cocaine chemically react to form cocaethylene • Cocaethylene Effects – Similar effects to cocaine – Greater cardiac toxicity than cocaine – 3-5x the half-life of cocaine – Associated with seizures, liver damage, compromised immune system
  • 101. Question 25 A. Acute respiratory distress syndrome B. Propylene glycol intoxication C. Mesenteric ischemia D. Cocaethylene formation
  • 105. Question 26 A. His prognosis for return of renal function to baseline is better than those of patients who have impaired left ventricular function B. In patients who have type 1 cardiorenal syndrome, the use of beta-adrenergic blockers worsens mortality C. This patient's acute on chronic renal dysfunction probably caused his acute heart failure (type 3 acute renocardiac syndrome) D. Addition of an angiotensin-converting enzyme inhibitor drug to this patient's chronic regimen will improve his 12- month mortality
  • 108. Question 27 A. Continue current management B. Discontinue albuterol nebulization C. Change intravenous fluid to 5% dextrose in water with 2 ampules of bicarbonate (100 mEq/L) D. Administer tromethamine (TRIS) buffer
  • 109. Pressure ventilation vs. volume ventilation Pressure-cycled modes deliver a fixed pressure at variable volume Volume-cycled modes deliver a fixed volume at variable pressure • Pressure-cycled modes • Pressure Support Ventilation (PSV) • Pressure Control Ventilation (PCV) • CPAP • BiPAP • Volume-cycled modes • Control Volume-cycled modes have the inherent • Assist risk of volutrauma. • Assist/Control • Intermittent Mandatory Ventilation (IMV) • Synchronous Intermittent Mandatory Ventilation (SIMV)
  • 112. Question 28 A. The modality allows the patient to define their inspiratory flow rate and tidal volume B. The incidence of barotrauma is less C. The need for tracheostomy to facilitate weaning is less D. Closed loop technology automatically adjusts the FIO2
  • 113. Question 29 Posterior reversible encephalopathy syndrome (PRES)
  • 114. Question 29 Conditions at Risk for PRES AJR 2008;29:1036-42
  • 116. Question 29 A. Contrast-enhanced magnetic resonance imaging of the brain B. Lumbar puncture and cerebrospinal fluid examination C. Intravenous contrast-enhanced computed tomography of the head D. Cerebral angiography
  • 118.
  • 119. Question 30 A. Discontinuation of lorazepam B. Initiation of zolpidem C. Discontinuation of methylprednisolone D. Discontinuation of inhaled beta-adrenergic agonists